Breast Cancer Recurrence - Risk, Therapy, and Surveillance
Dr. Antonio Wolff is a Professor of Oncology at Johns Hopkins University and is Director of Breast Cancer Trials in the Women’s Malignancies Program at the Johns Hopkins Kimmel Comprehensive Cancer Center. He is a practicing breast cancer medical oncologist and translational investigator with expertise in therapeutic clinical trials, biomarker development and implementation, survivorship, clinical practice guidelines, and quality initiatives. He is past member of American Society of Clinical Oncology’s Quality of Care Committee and past Chair of ASCO’s Clinical Practice Guidelines Committee. He is Panel Co-Chair and a lead author/senior author of the ASCO/College of American Pathology clinical practice guidelines on HER2 and hormone receptor testing in breast cancer. He has experience in collaborative, multidisciplinary national and international breast cancer clinical trials and on the integration of research findings into clinical practice. He serves as Chief Operating Officer of the Translational Breast Cancer Research Consortium. In 2009, he received an NCI Cancer Clinical Investigator Team Leadership Award. He serves as Chair of the ECOG-ACRIN Breast Cancer Committee and as member of the Breast Cancer Steering Committee as part of the NCI-funded National Clinical Trials Network (NCTN). He is a Fellow of ASCO and served as a Susan G. Komen Scholar between 2010-2021 and again as of 2023. He was identified in 2017 by Clarivate Analytics (Thomson Reuters) as one of the world’s most highly cited researchers (top 1% in clinical medicine). Dr. Wolff served as Associate Editor of Journal of Clinical Oncology between 2012-2022. At Johns Hopkins, he is a member of the Professorial Promotions Committee of the School of Medicine, and was inducted in 2018 in the JHU Miller Coulson Academy of Clinical Excellence. As part of the 125th anniversary celebration of the JHU School of Medicine, he was also recognized as one of 125 Living the Hopkins Mission Honorees, who were selected for their outstanding dedication to the institution’s core values of excellence and discovery, leadership and integrity, diversity and inclusion, and respect and collegiality.